Evidence map›Paper›PMID 32026412›Full record

ArticlePulmonary therapy2019

Dehydroepiandrosterone Supplementation May Benefit Women with Asthma Who Have Low Androgen Levels: A Pilot Study.

Nadzeya Marozkina, Joe Zein, Mark D DeBoer, Laurie Logan, Laura Veri, Kristie Ross, Benjamin Gaston

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Pulmonary therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05623059 phase1 / phase2completednot on this mapstarted 2023, after this paper: background citation

Phase IIa Clinical Trial to Evaluate Pharmacokinetics and Safety of Slow Release DHEA

TypeinterventionalSponsorIndiana UniversityRan2023 to 2025Enrolled18ConditionsAsthma, GenotypeArmsSlow Release DHEA
NCT07179952 phase2not yet recruitingnot on this mapstarted 2027, after this paper: background citation

A Study to Evaluate Efficacy and Safety of Slow Release DHEA

TypeinterventionalSponsorIndiana UniversityRan2027 to 2028Enrolled30ConditionsAsthmaArmsSlow Release DHEA, Placebo
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Proceedings of the National Academy of Sciences of the United States of America · 2020
    Trial
  2. Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases.Clinical reviews in allergy & immunology · 2026
    Review
  3. The testosterone paradox in asthma.Frontiers in allergy · 2026
    Review
  4. Review
  5. Sex, hormones, and lung health.Physiological reviews · 2026
    Review
  6. Sex Differences in Asthma Pathogenesis.Immunological reviews · 2026
    Review
  7. Article
  8. Association between orchiectomy and asthma: Insights from 2 population-based cohorts.The journal of allergy and clinical immunology. Global · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The Influence of Sex Hormones and X Chromosome in Immune Responses.Current topics in microbiology and immunology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Sex and gender in asthma.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  19. Benefits of Airway Androgen Receptor Expression in Human Asthma.American journal of respiratory and critical care medicine · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nadzeya MarozkinaCase Western Reserve University, Cleveland, OH, USA.
Joe ZeinCase Western Reserve University, Cleveland, OH, USA.
Mark D DeBoerUniversity of Virginia, Charlottesville, VA, USA.
Laurie LoganRainbow Babies and Children's Hospital, Cleveland, OH, USA.
Laura VeriRainbow Babies and Children's Hospital, Cleveland, OH, USA.
Kristie RossCase Western Reserve University, Cleveland, OH, USA.
Benjamin GastonCase Western Reserve University, Cleveland, OH, USA. begaston@iu.edu.
Rainbow Babies & Children's Hospital · USCase Western Reserve University · USUniversity of Virginia · US

Funding

Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.P01HL128192 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN · 2016 to 2020
$12.2M
Gender-based precision care for asthmaK08HL133381 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI ZEIN, JOE · 2017 to 2021
$836k
NHLBI NIH HHS K08 HL133381NHLBI NIH HHS P01 HL128192SARP U10HL109250
6 · The paper itself

Abstract

introductionAmong individuals with severe asthma, FEV

methodsPremenopausal, nonsmoking, otherwise healthy women, 18-50 years old, with mild or moderate asthma and baseline FEV

resultsSerum DHEAS increased with DHEA treatment in women with starting DHEAS < 200 µg/dL: this increase was from 71 ± 23 to 725 ± 295 µg/dL (n = 10; p = 0.0001). The increase in the high-DHEAS group was smaller. Post-albuterol FEV

conclusionsEndocrine treatments (corticosteroids) are a mainstay of anti-inflammatory management for moderate and severe asthma. Their use has improved asthma outcomes. Androgens also reduce airway inflammation and promote airway smooth muscle relaxation, but are rarely used clinically for asthma treatment. Our results suggest that the over-the-counter steroid DHEA may improve lung function in asthma outcomes among women with DHEAS < 200 ug/dL.

Indexed as

AsthmaDehydroepiandrosterone (DHEA)Lung function

Identifiers

PMID32026412
PMCPMC6967310
OpenAlexW2981522170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.